News Search Results
Aug 12, 2026, 16:10 ET 6 Greenberg Traurig Intellectual Property Attorneys Listed in 2026 IAM Strategy 300
including biochemistry, bioenergy systems, cell signaling, diagnostics, genetics, immunology, microbiome, nanoparticle carriers, nucleic acids, synthetic biology, and therapeutics. Harburger works closely with clients from early formation through growth and exit, establishing robust patent estates necessary
More news about: Greenberg Traurig, LLP
Aug 11, 2026, 05:56 ET NUS researchers achieve breakthrough in engineering colour-sensing yeast
yeast is one of biotechnology's most important microorganisms. It has long been used to leaven bread and ferment beer. More recently, advances in synthetic biology have enabled engineered yeast to convert sugar into a wide range of products, including medicines, fuels and industrial chemicals. Yet
More news about: National University of Singapore
Aug 06, 2026, 09:00 ET Scrum Studio and Tokyu Land Corporation Announce 13 Startups Selected for Full Bloom 2026, a Business Co-Creation Program Driving Creative Deeptech from Shibuya
Bio is digitizing smell. Its chips mimic the incredible power of insect olfaction (smell) to provide real-time chemical sensing. They combine synthetic biology and AI to produce an 'insect nose on a chip' - providing quantitative chemical measurement in near-real-time. This is a platform technology and
More news about: Scrum Ventures
Jul 28, 2026, 08:00 ET Matterworks Launches PyxisLabs to Scale Biochemical Omics and Predictive Biology
been rigorously tested against real-world benchmarks and validated by early-adoption users across the biopharma, health science, diagnostic, synthetic biology, and contract research industries. "At Matterworks, we envision a future where biology is foreseeable, not empirical. So, we are building
More news about: Matterworks
Jul 24, 2026, 10:30 ET Asymchem's Dunhua 2 Carbapenem Manufacturing Site Successfully Completes its First FDA Inspection for Continuous Manufacturing of an API
Europe, Asymchem employs more than 10,000 professionals worldwide, delivers a broad range of services including small molecule, TIDES, biologics, synthetic biology, and more. The company's ongoing investments in innovation and sustainability continue to drive value for its global client base.For
More news about: Asymchem Laboratories
Jul 22, 2026, 11:38 ET Airlift Bioreactors Market to Reach USD 8.20 Billion by 2035 as Biopharmaceutical Production and Single-Use Bioprocessing Drive Industry Growth | Future Market Insights
billion between 2025 and 2035. Increasing investments in biopharmaceutical manufacturing, expanding use of single-use bioreactors, and advancements in synthetic biology and bioprocess automation are expected to support long-term market expansion.Key Airlift Bioreactors Market Highlights at a Glance
More news about: Future Market Insights
Jul 22, 2026, 05:31 ET Precision Fermentation Ingredient Supplier Market to Reach USD 21.8 Billion by 2036, Driven by Commercial Scale-Up of Animal-Identical Proteins
improve product functionality, ensure supply chain stability, and reduce dependence on conventional livestock production. Continued advancements in synthetic biology, fermentation technologies, and downstream processing are further strengthening market prospects worldwide.The market is expected to create
More news about: Future Market Insights
Jul 21, 2026, 08:32 ET College of Pharmacy, Pusan National University Study Explores Rare Atom-Containing Natural Products and Their Biomedical Potential
valuable framework for discovering new bioactive natural products and biosynthetic enzymes with applications in drug discovery, biocatalysis, and synthetic biology. Understanding how nature incorporates atypical atoms into complex molecules may also inspire the development of novel pharmaceuticals, environmentally
More news about: Pusan National University
Jul 20, 2026, 12:46 ET Frost & Sullivan Celebrates 65 Years of Enabling Growth at Landmark 20th GIL Summit in Shanghai
investment trends defining China's next phase of development. Sessions will span artificial intelligence, intelligent industries, life sciences, synthetic biology, green energy, capital markets and other emerging technologies transforming the global economy."For 65 years, Frost & Sullivan has
More news about: Frost & Sullivan
Jul 20, 2026, 12:46 ET Frost & Sullivan Celebrates 65 Years of Enabling Growth at Landmark 20th GIL Summit in Shanghai
investment trends defining China's next phase of development. Sessions will span artificial intelligence, intelligent industries, life sciences, synthetic biology, green energy, capital markets and other emerging technologies transforming the global economy."For 65 years, Frost & Sullivan has
More news about: Frost & Sullivan
Jul 16, 2026, 02:55 ET GIMM Festival brings leading microbiology experts to Lisbon to discuss emerging viruses, antimicrobial resistance and biological engineering
antimicrobial resistance and bacterial evolution, emerging viruses and preparedness for future pandemics, as well as microorganism engineering and synthetic biology.Antimicrobial resistance is considered by the World Health Organization one of the greatest threats to global health, with the potential
More news about: Fundação GIMM - Gulbenkian Institute for Molecular Medicine
Jul 08, 2026, 10:17 ET Tsingke Highlights AI-Driven CLDN18.2 Antibody Discovery at AIS 2026
About TsingkeTsingke Biotech is a leading innovator in synthetic biology, with a mission to build "the world's great gene factory." Combining proprietary reagents, consumables, and synthesis equipment with AI-driven
More news about: Beijing Tsingke Biotech Co., Ltd.
Jul 08, 2026, 10:17 ET Tsingke Highlights AI-Driven CLDN18.2 Antibody Discovery at AIS 2026
characterization.About TsingkeTsingke Biotech is a leading innovator in synthetic biology, with a mission to build "the world's great gene factory." Combining proprietary reagents, consumables, and synthesis equipment with AI-driven
More news about: Beijing Tsingke Biotech Co., Ltd.
Jul 07, 2026, 10:01 ET Gene Editing Market to Reach US$30.5 Billion by 2033 as Precision Medicine and CRISPR Innovation Accelerate Growth - Persistence Market Research
Gene Switches, Repressible Gene Switches), Technology (CRISPR-based Systems, Zinc Finger Proteins (ZFP), Others), Application (Gene Therapy, Synthetic Biology, Others), and Regional Analysis for 2026 - 2033
More news about: Persistence Market Research Pvt. Ltd.
Jul 06, 2026, 08:55 ET As AI Models Become Commodities, a Bio-Native AI Company Just Moved to Patent the Data Layer Beneath the Models
partnership or comparable performance.Absci (NASDAQ: ABSI) is a clinical-stage biopharmaceutical company that applies generative AI and synthetic biology to design antibody therapeutics, pairing AI models with high-throughput wet-lab validation. Absci illustrates the AI-native, model-plus-wet-lab
More news about: USA News Group
Jul 03, 2026, 05:21 ET China-Eurasia Expo deepens regional business ties
rescue, oil and power facility inspection, modern agricultural operations and medical supply delivery in remote areas.In addition, two synthetic biology manufacturers based in Wusu, Xinjiang, showcased local industrial achievements and advances in fostering new quality productive forces at the
More news about: China Daily
Jun 30, 2026, 10:17 ET Tsingke Biotech Hosts Shanghai Salon on Oligonucleotide Drugs, Spotlighting Next-Gen RNA Therapeutics
worldwide.About Tsingke BiotechTsingke Biotech is a leading innovator in synthetic biology, with a mission to build "the world's great gene factory." Combining proprietary reagents, consumables, and synthesis equipment with AI-driven
More news about: Tsingke Biotech
Jun 30, 2026, 10:17 ET Tsingke Biotech Hosts Shanghai Salon on Oligonucleotide Drugs, Spotlighting Next-Gen RNA Therapeutics
worldwide.About Tsingke BiotechTsingke Biotech is a leading innovator in synthetic biology, with a mission to build "the world's great gene factory." Combining proprietary reagents, consumables, and synthesis equipment with AI-driven
More news about: Tsingke Biotech
Jun 30, 2026, 09:00 ET Bota Biosciences and BASF Introduce Bio-Identical Collagen III Powered by AI
world-leading Physical AI-driven biofoundry capabilities with BASF's premier technology for cosmetic actives. Drawing on their combined expertise in AI, synthetic biology, skin science, and biomanufacturing, Bota and BASF screened over 2,000 collagen fragments. Candidate evaluation ran in parallel with industrial
More news about: Bota Biosciences
Jun 29, 2026, 15:43 ET National STEM Festival® Brings Together America's Brightest Young Innovators and Industry Leaders to Celebrate the Future of STEM
hands-on experiences led by industry and community partners, including:The Curiosity Cube™, where visitors conducted synthetic biology experiments alongside MilliporeSigma scientists.The ACE Mobile Lab, featuring advanced manufacturing technologies including CNC
More news about: EXPLR
Jun 26, 2026, 10:30 ET Key Milestone Achieved: NDA for Sumecigrel Capsule, an Antiplatelet Innovative Drug by Vcare PharmaTech, Officially Accepted
has been accredited with multiple honors including Nanjing Key Laboratory for AI-Aided Drug Design and Nanjing Engineering Research Center for Synthetic Biology and Flow Chemistry. Its AI-assisted directed enzyme mutation technology was recognized as an Advanced Cleaner Production Technology of Nanjing.
More news about: Jiangsu Vcare Pharmatech Co., Ltd.
Jun 25, 2026, 13:24 ET Precision Fermentation Ingredients Market to Reach USD 136.6 Billion by 2036 as Biotechnology Innovation Accelerates Sustainable Ingredient Production, FMI
food production is further strengthening market opportunities globally.Technology & Innovation TrendsAdvancements in synthetic biology, microbial engineering, and fermentation optimization are reshaping the future of ingredient manufacturing. Companies are investing in engineered
More news about: Future Market Insights
Jun 17, 2026, 09:15 ET LUNAI BIOWORKS: CEO LETTER TO SHAREHOLDERS
entirely. COVID demonstrated the global health and economic cost of a biological event. The prospect of deliberate bioweapon creation through synthetic biology represents an equally grave but far less recognized threat.Governments are responding. The recognition that the next biological crisis—pandemic
More news about: Lunai Bioworks Inc.
Jun 17, 2026, 08:00 ET Azitra, Inc. CEO Issues Letter to Shareholders Detailing Strategic Reorientation Initiatives and Outlook for 2026 and Beyond
took meaningful steps to reorient the Company's strategic vision towards programs with near term value creating milestones. The confluence of synthetic biology and artificial intelligence is transforming the future of biological products, whether they be therapeutics, cosmetics or biotech tools. Our opportunity
More news about: Azitra, Inc.
Jun 15, 2026, 08:10 ET Harbour BioMed and BioMap Jointly Initiate MegaStream TechBio: A Leading Global Drug Development Platform Joins Forces with Premier Life Science Foundation Models to Set New Benchmarks for AI-Driven Complex Biologics R&D
over 800 institutional users worldwide, spanning multiple verticals including antibody and protein, innovative therapies and precision medicine, synthetic biology, and frontier scientific research. For more information, please visit www.biomap.com.
More news about: Harbour BioMed